Profile of Psychopharmaceutical Drug Use among Clients at the Baddoka Makassar National Narcotics Board Rehabilitation Centre

Fajriansyah Fajriansyah; Andi Paluseri; Vina Jihanita Eka Putri

Authors

Fajriansyah Fajriansyah Bagian Farmakologi dan Farmasi Klinik, Fakultas Ilmu Kesehatan Universitas Almarisah Madani, Makassar, Indonesia
Andi Paluseri Bagian Farmakologi dan Farmasi Klinik, Fakultas Ilmu Kesehatan Universitas Almarisah Madani, Makassar, Indonesia
Vina Jihanita Eka Putri Bagian Farmakologi dan Farmasi Klinik, Fakultas Ilmu Kesehatan Universitas Almarisah Madani, Makassar, Indonesia

Keywords:

Psychopharmaceutical, Rehabilitation, National Narcotics Board

Abstract

Baddoka Makassar National Narcotics Board Rehabilitation Center is one of the institutions with rehabilitation missions and functions to provide treatment, care and recovery to drug addicts or victims. Rehab clients typically suffer from psychiatric disorders, anxiety disorders, or depression. The main treatment for this disease is psychosocial therapy and psychiatric medication. This study aims to determine the patterns of psychotropic drug use among clients of the BNN Baddoka Makassar rehabilitation center. This study is a non-experimental descriptive study. A retrospective data collection was conducted from July to December 2022 which received psychopharmacological treatment and then entered the data into Microsoft Excel and then analyzed it as a percentage. The data obtained showed that the most commonly used psychiatric drug was fluoxetine, an SSRI antidepressant monotherapy, at 12.13%. The most common psychotropic combination was risperidone and trihexyphenidyl (9.24%).

References

A. S. Diasari, A. A. Prayitno Setiadi, and L. Nurmayanti, “Hubungan antara Karakteristik Pasien dan Terapi terhadap Nilai Retensi di RSJ Menur Surabaya,” J. Ilmu Kefarmasian Indones., vol. 17, no. 2, p. 132, 2019, doi: 10.35814/jifi.v17i2.535.

M. Miswanto and T. Tarya, “Implementasi Program Rehabilitasi Narkoba Berbasis Masyarakat di Pusat Rehabilitasi Narkoba ar-Rahman Tegal Binangun Palembang,” Intizar, vol. 23, no. 1, p. 113, 2017, doi: 10.19109/intizar.v23i1.1272.

Irwan Jasa Tarigan, Peran Badan Narkotika Nasional dengan Organisasi Sosial Kemasyarakatan dalam Penanganan Pelaku Penyalahgunaan Narkotika. Deepublish, 2017.

Pusat Penilitian Data dan Informasi BNN, “Indonesia Drugs Report,” Paper Knowledge . Toward a Media History of Documents, vol. 5, no. 2. pp. 40–51, 2021.

N. R. Said, M. T. Maloko, and N. T. Sanusi, “Metode Therapeutic Community Bagi Residen Di Balai Rehabilitasi Bnn Baddoka Makassar Perspektif Hukum Islam,” J. Al-Qadau Peradil. dan Huk. Kel. Islam, vol. 6, no. 2, pp. 269–286, 2019, doi: 10.24252/al-qadau.v6i2.10804.

T. Maslihatin, “Sistem Asosiasi Penyusunan Obat Pada Apotek Balai Rehabilitasi Badan Narkotika Nasional Baddoka Menggunakan Algoritma Apriori,” Celeb. Comput. Sci. J., vol. 2 No 2, no. 2020-10–30, pp. 27–38, 2020, [Online]. Available: http://journal.lldikti9.id/ccsj/article/view/518

S. Novitayani, “Psychopharmacology Therapy on Outpatients in the Aceh Psychiatric Hospital,” Idea Nurs. Journl, no. 2016, 2018.

Astiani, “Gejala Perilaku Penyalahguna Methapetamin Berdasarkan Status Gizi Di Balai Rehabilitasi Badan Narkotika Nasional Baddoka Makassar,” J. Muslim Community Heal., vol. 1, no. 3, pp. 87–99, 2020, [Online]. Available: http://pasca-umi.ac.id/index.php/jmch/article/download/257/273/1031 Diakses pada tanggal 8 Juni 2022

A. Rahmawati, “Hubungan Tingkat Depresi dengan Jenis Tahap Rehabilitasi Pada Residen Narkoba,” J. Kesehat., vol. 6, no. 2, 2019.

Mustamin, “Studi Tentang Penyebab Penggunaan Narkoba Dikalangan Remaja di Kelurahan Penana’e Kecamatan Raba Kota Bima,” J. Ilm. Mandala Educ., vol. 1, no. 2, pp. 237–249, 2015.

M. Al Ansari, A. Amirullah, and R. Ruslan, “Kerjasama Orang Tua, Sekolah, dan Pemerintah dalam Upaya Pencegahan Penyalahgunaan Narkoba pada Remaja,” J. Ilm. Pendidik. Pancasila dan Kewarganegaraan, vol. 5, no. 2, p. 416, 2020, doi: 10.17977/um019v5i2p416-426.

“Medscape.” [Online]. Available: https://reference.medscape.com/

W. Musdalifah, R. Susanti, and Robiyanto, “Evaluasi Penggunaan Obat Triheksifenidil Sebagai Terapi Adjuvan Pada Pasien Skizofrenia di Instalasi Rawat Inap Rumah Sakit Jiwa Daerah Sungai Bangkong Pontianak,” J. Mhs. Farm. Fak. …, vol. 4, no. 1, pp. 1–12, 2019, [Online]. Available: https://jurnal.untan.ac.id/index.php/jmfarmasi/article/view/43955%0Ahttps://jurnal.untan.ac.id/index.php/jmfarmasi/article/viewFile/43955/75676587791

A. P. Panjaitan and T. Septa, “Diagnosis Dini Depresi Pasca Studi Kasus di RS Jiwa Provinsi Lampung,” J. Ilm. Mhs. Kedokt. Indones., vol. 6, no. 2, pp. 4–12, 2018.

R. Yulyanti and A. Yulinar Ramdiani, “Analisis Potensi Interaksi Obat Antidepresan pada Pasien Skizofrenia di Rumah Sakit Swasta Bandung Januari - Juni 2021,” J. Sos. Sains, vol. 1, no. 10, pp. 1170–1180, 2021, doi: 10.59188/jurnalsosains.v1i10.225.

F. N. E. Eddy, T. Septa, and D. I. Angraini, “Diagnosis dan Tatalaksana Skizofrenia Hebefrenik Putus Obat dengan Logorrhea,” J. Medula Unila, vol. 7, no. 3, pp. 17–21, 2017.